Clinical trial
A Randomised, Partly-blinded Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Bacterial Vaginosis Compared With an Untreated Control Group
NCT06123299 is registered in ClinicalTrials.gov with Gedea Biotech AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Partly-blinded Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Bacterial Vaginosis Compared With an Untreated Control Group
- Lead sponsor
- Gedea Biotech AB
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 20, 2023
- Completion date
- September 4, 2024
- Enrollment
- 61 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
bacterial vaginosis